207 related articles for article (PubMed ID: 17311611)
1. New molecular targets for hepatocellular carcinoma: the ErbB1 signaling system.
Berasain C; Castillo J; Prieto J; Avila MA
Liver Int; 2007 Mar; 27(2):174-85. PubMed ID: 17311611
[TBL] [Abstract][Full Text] [Related]
2. The epidermal growth factor receptor: a link between inflammation and liver cancer.
Berasain C; Perugorria MJ; Latasa MU; Castillo J; Goñi S; Santamaría M; Prieto J; Avila MA
Exp Biol Med (Maywood); 2009 Jul; 234(7):713-25. PubMed ID: 19429859
[TBL] [Abstract][Full Text] [Related]
3. New therapies for hepatocellular carcinoma.
Avila MA; Berasain C; Sangro B; Prieto J
Oncogene; 2006 Jun; 25(27):3866-84. PubMed ID: 16799628
[TBL] [Abstract][Full Text] [Related]
4. Cyclooxygenase-2 in hepatocellular carcinoma.
Wu T
Cancer Treat Rev; 2006 Feb; 32(1):28-44. PubMed ID: 16337744
[TBL] [Abstract][Full Text] [Related]
5. From molecular biology to targeted therapies for hepatocellular carcinoma: the future is now.
Pang RW; Poon RT
Oncology; 2007; 72 Suppl 1():30-44. PubMed ID: 18087180
[TBL] [Abstract][Full Text] [Related]
6. Targeted therapy of hepatocellular cancer.
Wysocki PJ
Expert Opin Investig Drugs; 2010 Feb; 19(2):265-74. PubMed ID: 20074016
[TBL] [Abstract][Full Text] [Related]
7. Treatment options for hepatocellular carcinoma.
Sandhu DS; Tharayil VS; Lai JP; Roberts LR
Expert Rev Gastroenterol Hepatol; 2008 Feb; 2(1):81-92. PubMed ID: 19072372
[TBL] [Abstract][Full Text] [Related]
8. Pathogenesis of hepatocellular carcinoma and molecular therapies.
Mínguez B; Tovar V; Chiang D; Villanueva A; Llovet JM
Curr Opin Gastroenterol; 2009 May; 25(3):186-94. PubMed ID: 19387255
[TBL] [Abstract][Full Text] [Related]
9. Molecular mechanisms of hepatocellular carcinoma.
Aravalli RN; Steer CJ; Cressman EN
Hepatology; 2008 Dec; 48(6):2047-63. PubMed ID: 19003900
[TBL] [Abstract][Full Text] [Related]
10. Strategy and mechanism for the prevention of hepatocellular carcinoma: phosphorylated retinoid X receptor alpha is a critical target for hepatocellular carcinoma chemoprevention.
Shimizu M; Takai K; Moriwaki H
Cancer Sci; 2009 Mar; 100(3):369-74. PubMed ID: 19068086
[TBL] [Abstract][Full Text] [Related]
11. Inflammation and liver cancer: new molecular links .
Berasain C; Castillo J; Perugorria MJ; Latasa MU; Prieto J; Avila MA
Ann N Y Acad Sci; 2009 Feb; 1155():206-21. PubMed ID: 19250206
[TBL] [Abstract][Full Text] [Related]
12. Systemic therapies in hepatocellular carcinoma.
Wörns MA; Weinmann A; Schuchmann M; Galle PR
Dig Dis; 2009; 27(2):175-88. PubMed ID: 19546557
[TBL] [Abstract][Full Text] [Related]
13. Thrombin-mediated hepatocellular carcinoma cell migration: cooperative action via proteinase-activated receptors 1 and 4.
Kaufmann R; Rahn S; Pollrich K; Hertel J; Dittmar Y; Hommann M; Henklein P; Biskup C; Westermann M; Hollenberg MD; Settmacher U
J Cell Physiol; 2007 Jun; 211(3):699-707. PubMed ID: 17323377
[TBL] [Abstract][Full Text] [Related]
14. Cell death and hepatocarcinogenesis: Dysregulation of apoptosis signaling pathways.
Schattenberg JM; Schuchmann M; Galle PR
J Gastroenterol Hepatol; 2011 Jan; 26 Suppl 1():213-9. PubMed ID: 21199533
[TBL] [Abstract][Full Text] [Related]
15. Prognostic markers and putative therapeutic targets for hepatocellular carcinoma.
Frau M; Biasi F; Feo F; Pascale RM
Mol Aspects Med; 2010 Apr; 31(2):179-93. PubMed ID: 20176048
[TBL] [Abstract][Full Text] [Related]
16. Aberrant iNOS signaling is under genetic control in rodent liver cancer and potentially prognostic for the human disease.
Calvisi DF; Pinna F; Ladu S; Pellegrino R; Muroni MR; Simile MM; Frau M; Tomasi ML; De Miglio MR; Seddaiu MA; Daino L; Sanna V; Feo F; Pascale RM
Carcinogenesis; 2008 Aug; 29(8):1639-47. PubMed ID: 18579559
[TBL] [Abstract][Full Text] [Related]
17. Growth factors as therapeutic targets in HCC.
Furuse J
Crit Rev Oncol Hematol; 2008 Jul; 67(1):8-15. PubMed ID: 18434184
[TBL] [Abstract][Full Text] [Related]
18. Amphiregulin: a new growth factor in hepatocarcinogenesis.
Berasain C; Castillo J; Perugorría MJ; Prieto J; Avila MA
Cancer Lett; 2007 Aug; 254(1):30-41. PubMed ID: 17321672
[TBL] [Abstract][Full Text] [Related]
19. Natural history of hepatocellular carcinoma and current treatment options.
Raoul JL
Semin Nucl Med; 2008 Mar; 38(2):S13-8. PubMed ID: 18243838
[TBL] [Abstract][Full Text] [Related]
20. Opportunities for targeted therapies in hepatocellular carcinoma.
Thomas MB; Abbruzzese JL
J Clin Oncol; 2005 Nov; 23(31):8093-108. PubMed ID: 16258107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]